Using pharmacogenomics to improve medicines use after myocardial infarction
Hospital Pharmacy Europe
MARCH 7, 2024
As clinicians, we know that there is inter-individual variability in medication response. We already use other information known to impact on risk of ADRs from a medication in our clinical practice. 17 In an analysis of 44,396 participants, we found that 57% of people in this group had a CYP2C19 LOF variant.
Let's personalize your content